RecruitingNCT06443346
Prospective Registry of EoSinophilic esOphagitis
Prospective Registry of EoSinophilic esOphagitis (PRESO)
Sponsor
IRCCS San Raffaele
Enrollment
1,000 participants
Start Date
Jun 1, 2024
Study Type
OBSERVATIONAL
Summary
This is a prospective registry of all the Eosinophilic Esophagitis (EoE) patients referred to the third level referral centre of San Raffaele Scientific Institute
Eligibility
Inclusion Criteria3
- Participant is willing and able to give informed consent for participation in the study.
- The medical product is the standard of care for the patient or the participant is taking the medicinal product according to clinical practice
- Being diagnosed with EoE as per guidelines of the disease
Exclusion Criteria2
- No clear diagnosis of EoE
- Not willing to provide informed consent to the inclusion in the registry
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHEREosinophilic Esophagitis
Eosinophilic Esophagitis patients with a proper diagnosis
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06443346